Health Care: Drugs

Sarepta Therapeutics Inc (SRPT: NASDAQ)

$36.26 1.54 | 4.44%
04/28/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 5.42M 1.25M 9.76M 14.22M
Cost of Sales 130.00K 0.00 0.00 0.00
Gross Operating Profit 5.29M 1.25M 9.76M 14.22M
Selling, General, and Administrative Expenses 83.75M 75.04M 49.31M 31.59M
Research & Development 188.27M 146.39M 94.23M 72.91M
Operating Income before D & A (EBITDA) -266.73M -220.18M -133.79M -90.28M
Depreciation & Amortization 5.69M 5.90M 6.12M 1.28M
Interest Income 0.00 154.00K 779.00K 326.00K
Other Income - Net 0.00 0.00 -2.78M -22.03M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -272.42M -225.93M -141.91M -113.26M
Interest Expense 535.00K 0.00 0.00 0.00
Pre-Tax Income -272.96M -225.93M -141.91M -113.26M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -267.26M -220.03M -135.79M -111.98M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -267.26M -220.03M -135.79M -111.98M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -267.26M -220.03M -135.79M -111.98M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-267.26M -220.03M -135.79M -111.98M
Preferred Dividends
Net Income Available To Common -267.26M -220.03M -135.79M -111.98M
Basic EPS from Continuing Ops. -5.49 -5.20 -3.39 -3.31
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -5.49 -5.20 -3.39 -3.31
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -5.49 -5.20 -3.39 -3.31
Basic Normalized Net Income/Share -5.49 -5.20 -3.39 -3.31
EPS fr Continuing Ops. -5.49 -5.20 -3.39 -3.31
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -5.49 -5.20 -3.39 -3.31
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -5.49 -5.20 -3.39 -3.31
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-5.49 -5.20 -3.39 -3.31
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with SRPT

Latest SRPT Headlines from TheStreet

More Financial News for SRPT

Press Releases for SRPT

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter